Cartography Biosciences

Private

Cartography Biosciences is a precision oncology company developing cancer immunotherapies guided by the first comprehensive antigen atlas for immuno-oncology targets. The company's proprietary ATLAS and SUMMIT platforms combine single-cell genomics, proteomics, and computational biology to identify tumor-selective antigens, enabling antibody-based therapies that target tumors more precisely than existing therapeutics.

Founders Kevin Parker, Ansuman Satpathy, Howard Chang
CEO Kevin Parker

Company

Founded
2020
Headquarters
South San Francisco, United States

Financials

Total Funding
$124M
Sectors
Biotech
cartography.bio Twitter

Funding History

3 rounds
Series B Oct 2, 2025
$67M
Pfizer Ventures (Lead) Andreessen Horowitz 8VC Wing Venture Capital Catalio Capital Management ARTIS Ventures AME Cloud Ventures Gaingels LG Corp Amgen Ventures Finchley H.V. Global BioAccess Fund Lotte Holdings CVC
Series A Jul 19, 2022
$57M
8VC (Lead) Andreessen Horowitz Wing Venture Capital Catalio Capital Management ARTIS Ventures Alexandria Venture Investments AME Cloud Ventures Gaingels
Seed Jun 1, 2021
Undisclosed
Andreessen Horowitz (Lead) Wing Venture Capital

Funding data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.